Daiwa Securities Group Inc. Repligen Corp Transaction History

Daiwa Securities Group Inc.

$27.1 Billion
Q2 2025

A detailed history of Daiwa Securities Group Inc. transactions in Repligen Corp stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 31,194 shares of RGEN stock, worth $4.64 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

31,194

Previous 24,046 29.73%

Holding current value

$4.64 Million

Previous $3.06 Million 26.8%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$108.89 - $145.23 $778,345 - $1.04 Million	7,148 Added 29.73%	31,194 $3.88 Million
Q4 2024 Feb 07, 2025	BUY	$123.41 - $160.92 $674,559 - $879,588	5,466 Added 29.42%	24,046 $3.46 Million
Q3 2024 Nov 12, 2024	SELL	$119.79 - $167.35 $827,149 - $1.16 Million	-6,905 Reduced 27.09%	18,580 $2.77 Million
Q2 2024 Aug 07, 2024	BUY	$120.0 - $182.95 $1.7 Million - $2.59 Million	14,166 Added 125.15%	25,485 $3.21 Million
Q1 2024 May 02, 2024	BUY	$170.78 - $208.42 $1.37 Million - $1.67 Million	8,019 Added 243.0%	11,319 $2.08 Million
Q4 2023 Jan 31, 2024	BUY	$114.17 - $185.35 $11,417 - $18,535	100 Added 3.13%	3,300 $593,000
Q3 2023 Nov 01, 2023	BUY	$138.78 - $176.51 $13,878 - $17,651	100 Added 3.23%	3,200 $509,000
Q2 2023 Jul 31, 2023	BUY	$138.42 - $180.31 $13,841 - $18,031	100 Added 3.33%	3,100 $439,000
Q4 2022 Feb 06, 2023	BUY	$162.42 - $220.56 $487,259 - $661,680	3,000 New	3,000 $508,000
Q4 2018 Feb 05, 2019	SELL	$48.26 - $68.88 $11,630 - $16,600	-241 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$30.92 - $37.27 $7,451 - $8,982	241 New	241 $9,000

Others Institutions Holding RGEN

# of Institutions

505

Shares Held

58.9M

Call Options Held

89.3K

Put Options Held

679K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.25B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Account

Daiwa Securities Group Inc. Repligen Corp Transaction History